530 results on '"Rancati, Tiziana"'
Search Results
102. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
103. 3362: Incorporating genetic information in dose-response relationships
104. sj-docx-1-tmj-10.1177_03008916221078061 – Supplemental material for Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study
105. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
106. Contouring Variability of the Penile Bulb on CT Images: Quantitative Assessment Using a Generalized Concordance Index
107. Repeatability and reproducibility of MRI-radiomic features: A phantom experiment on a 1.5 T scanner.
108. Late Fecal Incontinence After High-Dose Radiotherapy for Prostate Cancer: Better Prediction Using Longitudinal Definitions
109. Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome
110. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
111. Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision
112. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
113. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study
114. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
115. Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review
116. Radiation Dose–Volume Effects in the Larynx and Pharynx
117. Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients
118. A Multicentre Evaluation of Dosiomics Features Reproducibility, Stability and Sensitivity
119. P-67 Dosimetric results and NTCP models comparison between VMAT and IMPT for nasopharyngeal cancer patients
120. NTCP Modeling of Subacute/Late Laryngeal Edema Scored by Fiberoptic Examination
121. To Bleed or Not to Bleed. A Prediction Based on Individual Gene Profiling Combined With Dose–Volume Histogram Shapes in Prostate Cancer Patients Undergoing Three-Dimensional Conformal Radiation Therapy
122. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational study
123. Dose–volume effects for normal tissues in external radiotherapy: Pelvis
124. Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy
125. Spatial descriptions of radiotherapy dose: normal tissue complication models and statistical associations
126. Editorial: Modeling for Prediction of Radiation-Induced Toxicity to Improve Therapeutic Ratio in the Modern Radiation Therapy Era
127. Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
128. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study
129. Editorial Comment to Health-related quality of life after carbon-ion radiotherapy for prostate cancer: A 3-year prospective study
130. Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective
131. Erratum to ‘Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations’[European Urology Oncology 2 (2019) 277-285]
132. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models
133. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
134. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
135. Reducing rectal injury during external beam radiotherapy for prostate cancer
136. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes
137. Modeling Outcome After Prostate IGRT
138. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies
139. Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects
140. Towards spatial representations of dose distributions to predict risk of normal tissue morbidity after radiotherapy
141. Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients
142. External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
143. Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects
144. How do prostate cancer patients navigate the active surveillance journey? A 3-year longitudinal study
145. T2w‐MRI signal normalization affects radiomics features reproducibility
146. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts
147. Predictive models of toxicity with external radiotherapy for prostate cancer: Clinical issues
148. Predictive models of toxicity in external radiotherapy: Dosimetric issues
149. 207 - TRANSFERABILITY OF KNOWLEDGE BASED (KB) PLAN PREDICTION MODELS FOR RIGHT-WHOLE BREAST IRRADIATION (R-WBI)
150. 517 - HIGH-PERFORMANCE CELLULAR RADIOSENSITIVITY ASSAY COMBINED TO A POLYGENIC SCORE TO PREDICT LATE POST RADIOTHERAPY OVERREACTION IN CANCER PROSTATE PATIENTS: A PROOF OF CONCEPT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.